Q1 Earnings Forecast for ELDN Issued By Leerink Partnrs
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) – Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Eledon Pharmaceuticals in a report released on Sunday, March 23rd. Leerink Partnrs analyst T. Smith expects that the company will post earnings per share of ($0.28) for the quarter. The consensus estimate for Eledon Pharmaceuticals’ current […]
